Article History
Received: 8 June 2020
Accepted: 1 September 2020
First Online: 29 September 2020
Compliance with ethical standards
:
: IML has received speaking and advisory board fees from Merck and Gilead Sciences. TB has received speaking fees from Pfizer and speaking, advisory board fees and research support from Gilead Sciences. CL has received research support from Gilead Sciences.